Grant Recipients

Alisa Lee Sherick MD

University of Colorado Denver

Targeting MerTK as an immunotherapeutic strategy in pediatric acute myeloid leukemia

Mirian Rosenberg, PhD

Hebrew University of Jerusalem/ The Children's Hospital of Philadelphia

Autoantigen discovery and immune profiling of Opsoclonus Myoclonus Syndrome

Shahrzad Bahrampour , Ph.D

The Hospital for Sick Children, Toronto

Unconventional role of volume-regulated anion channel in pediatric brain tumor

Funded by #ColbyStrong

Aasef G. Shaikh MD,PhD

Functional Electrical Stimulation Institute

Membranes and Models - Towards Targeted Therapy of Opsoclonus

Funded in partnership with The Viswanatha Family + Friends

Patricia Denise B. Tiburcio, PhD

University of Texas, Southwestern

Targeting Proteasome and mTOR pathways in Actinomycin-Resistant Wilms Tumors

Funded by Funded by Gentleman Toker In Honor of Michelle Laderman

Delfim Duarte, MD PhD

Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal

Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia

Amy Erbe-Gurel, PhD

University of Wisconsin

Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities

Dung-Fang Lee, PhD

The University of Texas Health Science Center

The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma

Vicki Huff, PhD

University of Texas M.D. Anderson Cancer Center

Assessment of a cancer preventive agent for Wilms tumor

Thais Armangue, MD, PhD

Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain

Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling

Grant Funded in Partnership with The Viswanatha Family + Friends

Julien Fleurence PhD, PharmD

Baylor College of Medicine

T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers

Lai Man (Natalie) Wu , PhD

Cincinnati Children’s Hospital Medical Center

Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy

Supported in part by Hanna's Hoops 4 Healing

Alexandra Stevens, MD, PhD

Baylor College of Medicine

Predicting Atovaquone-Induced Apoptosis in Pediatric AML

Grant Rowe, MD PhD

Children’s Hospital Boston

Targeting leukemia stem cells in infant B-lymphoblastic leukemia

This grant is funded by Change a Life Foundation

Laura Perin, PhD

Children's Hospital Los Angeles

Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?

Surinder Kumar, PhD

University of Michigan

The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma

This grant is funded by Peloton Magazine

Kathryn Lemberg, md, phd

Johns Hopkins University - School of Medicine

Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors

W. Clay Gustafson, md, phd

University of California San Francisco

Drugging the Aurora Kinase A Interactome in Neuroblastoma